132 related articles for article (PubMed ID: 12212983)
1. The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection.
Field JK; Youngson JH
Eur Respir J; 2002 Aug; 20(2):464-79. PubMed ID: 12212983
[TBL] [Abstract][Full Text] [Related]
2. The Liverpool Lung Project research protocol.
Field JK; Smith DL; Duffy S; Cassidy A
Int J Oncol; 2005 Dec; 27(6):1633-45. PubMed ID: 16273220
[TBL] [Abstract][Full Text] [Related]
3. Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.
Cassidy A; Myles JP; Liloglou T; Duffy SW; Field JK
Int J Oncol; 2006 May; 28(5):1295-301. PubMed ID: 16596247
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer epigenetics and genetics.
Risch A; Plass C
Int J Cancer; 2008 Jul; 123(1):1-7. PubMed ID: 18425819
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.
Raji OY; Agbaje OF; Duffy SW; Cassidy A; Field JK
Cancer Prev Res (Phila); 2010 May; 3(5):664-9. PubMed ID: 20424129
[TBL] [Abstract][Full Text] [Related]
6. Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
Bravo-Iñiguez CE; Fox SW; De Leon LE; Tarascio JN; Jaklitsch MT; Jacobson FL
J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1248-1254.e1. PubMed ID: 31248631
[TBL] [Abstract][Full Text] [Related]
7. LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence.
Marcus MW; Chen Y; Raji OY; Duffy SW; Field JK
Cancer Prev Res (Phila); 2015 Jun; 8(6):570-5. PubMed ID: 25873368
[TBL] [Abstract][Full Text] [Related]
8. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.
Raji OY; Duffy SW; Agbaje OF; Baker SG; Christiani DC; Cassidy A; Field JK
Ann Intern Med; 2012 Aug; 157(4):242-50. PubMed ID: 22910935
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer chemoprevention: an integrated approach.
Lippman SM; Spitz MR
J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
[TBL] [Abstract][Full Text] [Related]
10. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
11. Utilizing Lung Cancer Risk Prediction Models to Promote Smoking Cessation: Two Randomized Controlled Trials.
Sherratt FC; Marcus MW; Robinson J; Field JK
Am J Health Promot; 2018 Jun; 32(5):1196-1205. PubMed ID: 27780895
[TBL] [Abstract][Full Text] [Related]
12. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.
Field JK; Brambilla C; Caporaso N; Flahault A; Henschke C; Herman J; Hirsch F; Lachmann P; Lam S; Maier S; Montuenga LM; Mulshine J; Murphy M; Pullen J; Spitz M; Tockman M; Tyndale R; Wistuba I; Youngson J
Int J Oncol; 2002 Aug; 21(2):369-73. PubMed ID: 12118333
[TBL] [Abstract][Full Text] [Related]
13. Future initiatives to reduce lung cancer incidence in the United Kingdom: smoking cessation, radon remediation and the impact of social change.
Denman AR; Rogers S; Timson K; Phillips PS; Crockett RG; Groves-Kirkby CJ
Perspect Public Health; 2015 Mar; 135(2):92-101. PubMed ID: 24607815
[TBL] [Abstract][Full Text] [Related]
14. Smoking-associated DNA methylation markers predict lung cancer incidence.
Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H
Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164
[TBL] [Abstract][Full Text] [Related]
15. EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.
Field JK; Liloglou T; Niaz A; Bryan J; Gosney JR; Giles T; Brambilla C; Brambilla E; Vesin A; Timsit JF; Hainaut P; Martinet Y; Vignaud JM; Thunnissen FB; Prinsen C; Snijders PJ; Smit EF; Sozzi G; Roz L; Risch A; Becker HD; Elborn JS; Magee ND; Montuenga LM; Pajares MJ; Lozano MD; O'Byrne KJ; Harrison DJ; Niklinski J; Cassidy A;
Eur Respir J; 2009 Dec; 34(6):1477-86. PubMed ID: 19948914
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility to lung cancer: implications for smoking cessation.
Houfek JF; Atwood JR
Medsurg Nurs; 2003 Feb; 12(1):45-9. PubMed ID: 12619599
[TBL] [Abstract][Full Text] [Related]
17. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
19. The molecular epidemiology of lung cancer.
Schwartz AG; Prysak GM; Bock CH; Cote ML
Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the Japan molecular epidemiology for lung cancer study.
Kawaguchi T; Ando M; Ito N; Isa S; Tamiya A; Shimizu S; Saka H; Kubo A; Koh Y; Matsumura A
Clin Lung Cancer; 2013 Sep; 14(5):596-600. PubMed ID: 23685138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
